Clarithromycin in 2003: sustained efficacy and safety in an era of rising antibiotic resistance
- 31 July 2004
- journal article
- review article
- Published by Elsevier in International Journal of Antimicrobial Agents
- Vol. 24 (1) , 1-17
- https://doi.org/10.1016/j.ijantimicag.2004.03.003
Abstract
No abstract availableKeywords
This publication has 130 references indexed in Scilit:
- Five days of cefprozil versus 10 days of clarithromycin in the treatment of an acute exacerbation of chronic bronchitisAnnals of Allergy, Asthma & Immunology, 2001
- Clarithromycin suppresses bronchial hyperresponsiveness associated with eosinophilic inflammation in patients with asthmaAnnals of Allergy, Asthma & Immunology, 2000
- ClarithromycinDrugs, 1997
- Results of the Alexander Project: A continuing, multicenter study of the antimicrobial susceptibility of community-acquired lower respiratory tract bacterial pathogensDiagnostic Microbiology and Infectious Disease, 1996
- A multicenter study of the antimicrobial susceptibility of community-acquired lower respiratory tract pathogens in the United States, 1992–1994Diagnostic Microbiology and Infectious Disease, 1996
- Overview of the safety profile of clarithromycin suspension in pediatric patientsThe Pediatric Infectious Disease Journal, 1993
- Comparison of clarithromycin and penicillin VK suspensions in the treatment of children with streptococcal pharyngitis and review of currently available alternative antibiotic therapiesThe Pediatric Infectious Disease Journal, 1993
- ClarithromycinDrugs, 1993
- ClarithromycinDrugs, 1992
- Clarithromycin in vitro activity enhanced by its major metabolite, 14-hydroxyclarithromycinDiagnostic Microbiology and Infectious Disease, 1992